Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Recently released market study: Drais Pharmaceuticals, Inc. - Product Pipeline Review - 2012


Print article Print article
2013-01-28 07:06:44 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Drais Pharmaceuticals, Inc. - Product Pipeline Review - 2012" provides data on the Drais Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Drais Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Drais Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/530144_drais_pharmaceuticals_inc_product_pip ..


Scope

* Drais Pharmaceuticals, Inc. - Brief Drais Pharmaceuticals, Inc. overview including business

description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Drais Pharmaceuticals, Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Drais Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Drais Pharmaceuticals, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Drais Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Drais Pharmaceuticals, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Drais Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Drais Pharmaceuticals, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Drais Pharmaceuticals, Inc. and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Drais Pharmaceuticals, Inc. Snapshot
Drais Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Drais Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Drais Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Drais Pharmaceuticals, Inc. - Pipeline Products Glance
Drais Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Drais Pharmaceuticals, Inc. - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Drais Pharmaceuticals, Inc. - Drug Profiles
ASP-3291
Product Description
Mechanism of Action
R&D Progress
ASP-7147
Product Description
Mechanism of Action
R&D Progress
DTS-108
Product Description
Mechanism of Action
R&D Progress
UNBS-5162
Product Description
Mechanism of Action
R&D Progress
Drais Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
Drais Pharmaceuticals, Inc. - Pipeline Products By Mechanism of Action
Drais Pharmaceuticals, Inc. - Recent Pipeline Updates
Drais Pharmaceuticals, Inc. - Dormant Projects
Drais Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Financial Deals Landscape
Drais Pharmaceuticals, Inc., Deals Summary
Drais Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Drais Pharma Secures $20 Million In Financing
Drais Pharma Secures $15 Million In Series A Financing
Licensing Agreements
Drais Pharma Enters Into Licensing Agreement With Diatos For DTS-108
Unibioscreen Enters Into Licensing Agreement With Drais Pharma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Drais Pharmaceuticals, Inc., Key Information
Drais Pharmaceuticals, Inc., Key Facts
Drais Pharmaceuticals, Inc. - Pipeline by Indication, 2012
Drais Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2012
Drais Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2012
Drais Pharmaceuticals, Inc. - Phase II, 2012
Drais Pharmaceuticals, Inc. - Phase I, 2012
Drais Pharmaceuticals, Inc. - Pre-Clinical, 2012
Drais Pharmaceuticals, Inc. - Pipeline By Route of Administration, 2012
Drais Pharmaceuticals, Inc. - Pipeline Products By Mechanism of Action, 2012
Drais Pharmaceuticals, Inc. - Recent Pipeline Updates, 2012
Drais Pharmaceuticals, Inc. - Dormant Developmental Projects,2012
Drais Pharmaceuticals, Inc., Deals Summary
Drais Pharma Secures $20 Million In Financing
Drais Pharma Secures $15 Million In Series A Financing
Drais Pharma Enters Into Licensing Agreement With Diatos For DTS-108
Unibioscreen Enters Into Licensing Agreement With Drais Pharma

List of Figures
Drais Pharmaceuticals, Inc. - Pipeline by Indication, 2012
Drais Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2012
Drais Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=530144&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com